Diagnostic and Interventional Cardiology

Left: Echocardiogram at birth shows severe non-delamination of the tricuspid valve septal leaflet, with coaptation point near the right ventricle apex (marked with arrow). The right ventricle is small, while the right atrium is large. Right: Jaxon’s echocardiogram today shows a normal tricuspid valve position (marked with arrow) and normal sizes of the right atrium and right ventricle.

From Severe Ebstein Anomaly to a Normal Heart

November 25, 2022 — Jodie Votava-Smith, MD, has pulled up two side-by-side echocardiograms on her computer screen and is ...

November 25, 2022

The Cardiovascular Research Foundation has announced its Inaugural Pulse‑Setter Awards, including Pulse-setter Champion and Women as One Co-Founder, Roxana Mehran, MD.

News | Cardiovascular Education

Women as One Co-Founder Among Four to Receive Inaugural CRF Awards

November 23, 2022 — The Cardiovascular Research Foundation (CRF) has announced its inaugural Pulse‑Setter Awards ...

November 23, 2022

Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value

News | Artificial Intelligence

Viz.ai Announces Positive New Data From Large Aortic Dissection AI Real-World Study at the 2022 VEITHsymposium

November 23, 2022 — Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today ...

November 23, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Nicholas Pajewski, Ph.D., associate professor of biostatistics and data science at Wake Forest University School of Medicine. Credit: Wake Forest University School of Medicine

News | Hypertension

Study Highlights Importance of Long-term Management of Hypertension

November 23, 2022 — In 2015, published findings from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) ...

November 23, 2022

Survivors face higher risk of cardiac events that can reduce their life expectancy by decades

News | Pediatric Cardiology

Exercise Testing Detects Silent Cardiovascular Dangers Common in Pediatric Cancer Survivors

November 23, 2022 — Cardiopulmonary exercise testing (CPET) can detect underlying early signs of cardiovascular problems ...

November 23, 2022

New research by Cedars-Sinai investigators supports evidence that social factors, such as unemployment, financial difficulties, racial discrimination and other stressors, affect an individual's health. Getty Images

News | Stroke

Racism, Stress and Stroke Outcomes

November 22, 2022 — investigators from the Department of Neurology at Cedars-Sinai have new information on stroke ...

November 22, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options

News | Heart Failure

Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population

November 22, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with ...

November 22, 2022

CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation as part of its TANDEM I study in Poland.

News | Heart Valve Technology

CroíValve Reports Successful First in Human Implants of its DUO Tricuspid Coaptation Valve System

November 22, 2022 — CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve ...

November 22, 2022

Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant Hypertensive Subjects at 50 mg Once Daily (p=0.01 vs. placebo)

News | Hypertension

Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension

November 21, 2022 — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to ...

November 21, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

UH Cleveland Medical Center. Image courtesy of University Hospitals

News | Deep Vein Thrombosis (DVT)

Four Prospective, Multicenter Studies Support Use of Drug-Coated Balloons Over Bare Metal Stents in Treating Femoropopliteal Lesions

November 21, 2022 — New research published in the Journal of the American College of Cardiology shows the use of drug ...

November 21, 2022

Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used.

News | Artificial Intelligence

High adopters of AI-enabled screening tool are more likely to diagnose left ventricular dysfunction than low adopters, Mayo Clinic study finds

November 21, 2022 — Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled ...

November 21, 2022

News | Hypertension

Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension

November 21, 2022 — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to ...

November 21, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association.

News | Heart Failure

Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology

November 21, 2022 — Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide ...

November 21, 2022

Justin Balko, PharmD, PhD, Ingram Associate Professor of Cancer Research, and a co-corresponding author of the study. Credit: Vanderbilt University Medical Center

News | Heart Failure

Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis

November 22, 2022 — Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint ...

November 21, 2022

Screen shots of Viz PE with RV/LV ratio data (left), along with the company’s ECG Viewer (right). Both are part of the comprehensive Viz Cardio Suite designed to speed and improve patient access to innovative cardiovascular treatments. Source: Viz.ai.

News | Pulmonary Embolism

Viz.ai Launches AI-Powered Viz Cardio Suite

November 17, 2022 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced the ...

November 17, 2022